| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | ML050 | CTRPv2 | pan-cancer | AAC | 0.0015 | 1 |
| mRNA | XMD8-92 | GDSC1000 | pan-cancer | AAC | 0.002 | 1 |
| mRNA | Mdivi-1 | CTRPv2 | pan-cancer | AAC | 0.0014 | 1 |
| mRNA | Cytarabine | GDSC1000 | pan-cancer | AAC | 0.0014 | 1 |
| mRNA | Methotrexate | GDSC1000 | pan-cancer | AAC | -0.0011 | 1 |
| mRNA | UNC0321 | CTRPv2 | pan-cancer | AAC | -0.0013 | 1 |
| mRNA | BRD-K44224150 | CTRPv2 | pan-cancer | AAC | 0.0023 | 1 |
| mRNA | Talazoparib | GDSC1000 | pan-cancer | AAC | 0.0011 | 1 |
| mRNA | CIL70 | CTRPv2 | pan-cancer | AAC | 0.0012 | 1 |
| mRNA | erastin | CTRPv2 | pan-cancer | AAC | -0.0007 | 1 |